Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA >> article
 
Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA
Editor:xuezhe    Clicks:0    Date:2022-8-2 17:30:13
Keyword: FDA&EMA
Healthoo Information:
Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
Baidu
map